Baxter Aktiengesellschaft

Guenther Schlag

Johann J Eibl

Heinz Redl

Harald Gasser

Seth Hallstroem

Thomas Seelich

Georg Habison

Edgar Scheel

Wolfgang Biering

Irmgard Schlag, Legal Representative

Hamza Mansour

The present invention provides a fibrinogen-based tissue adhesive which contains an elastase inhibitor.

Fibrinogen-based tissue adhesive containing an elastase inhibitor

Fibrinogen-based tissue adhesive

The invention relates to a hemostatic sponge based on collagen and an activator or proactivator of blood coagulation homogeneously distributed therein, which is dried and contains a water content of at least 2%, preferably in the range of 2 to 25%, more preferred 10 to 20%, and a method for producing this sponge.

Hemostatic sponge based on collagen

There is disclosed a stable, virus-safe, pharmaceutical preparation comprising thiol-group-containing proteins which are heat-treated and processed such that at least 40% of the thiol groups are capable of being nitrosated, a method of preparing such preparations as well as the use of these preparations.

Preparation comprising thiol-group-containing proteins

Growing community of inventors

Vienna, Austria

Guenther Schlag